TY - JOUR PY - 2012 DA - 2012// TI - Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(11)61625-5 DO - 10.1016/S0140-6736(11)61625-5 ID - ref1 ER - TY - JOUR AU - Goldhirsch, A. AU - Wood, W. C. AU - Coates, A. S. AU - Gelber, R. D. AU - Thürlimann, B. AU - Senn, H. -. J. PY - 2011 DA - 2011// TI - Panel members. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdr304 DO - 10.1093/annonc/mdr304 ID - Goldhirsch2011 ER - TY - JOUR AU - Sinn, P. AU - Aulmann, S. AU - Wirtz, R. AU - Schott, S. AU - Marmé, F. AU - Varga, Z. PY - 2013 DA - 2013// TI - Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility JO - Geburtshilfe Frauenheilkd VL - 73 UR - https://doi.org/10.1055/s-0033-1350831 DO - 10.1055/s-0033-1350831 ID - Sinn2013 ER - TY - JOUR AU - Perou, C. M. AU - Sørlie, T. AU - Eisen, M. B. AU - Rijn, M. AU - Jeffrey, S. S. AU - Rees, C. A. PY - 2000 DA - 2000// TI - Molecular portraits of human breast tumours JO - Nature VL - 406 UR - https://doi.org/10.1038/35021093 DO - 10.1038/35021093 ID - Perou2000 ER - TY - JOUR AU - Sørlie, T. PY - 2004 DA - 2004// TI - Molecular portraits of breast cancer: tumour subtypes as distinct disease entities JO - Eur J Cancer VL - 40 UR - https://doi.org/10.1016/j.ejca.2004.08.021 DO - 10.1016/j.ejca.2004.08.021 ID - Sørlie2004 ER - TY - JOUR AU - Hu, Z. AU - Fan, C. AU - Oh, D. S. AU - Marron, J. S. AU - He, X. AU - Qaqish, B. F. PY - 2006 DA - 2006// TI - The molecular portraits of breast tumors are conserved across microarray platforms JO - BMC Genomics VL - 7 UR - https://doi.org/10.1186/1471-2164-7-96 DO - 10.1186/1471-2164-7-96 ID - Hu2006 ER - TY - JOUR AU - Parker, J. S. AU - Mullins, M. AU - Cheang, M. C. U. AU - Leung, S. AU - Voduc, D. AU - Vickery, T. PY - 2009 DA - 2009// TI - Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes JO - JCO VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.1370 DO - 10.1200/JCO.2008.18.1370 ID - Parker2009 ER - TY - JOUR AU - Nielsen, T. AU - Wallden, B. AU - Schaper, C. AU - Ferree, S. AU - Liu, S. AU - Gao, D. PY - 2014 DA - 2014// TI - Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-177 DO - 10.1186/1471-2407-14-177 ID - Nielsen2014 ER - TY - JOUR AU - Cheang, M. C. U. AU - Chia, S. K. AU - Voduc, D. AU - Gao, D. AU - Leung, S. AU - Snider, J. PY - 2009 DA - 2009// TI - Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp082 DO - 10.1093/jnci/djp082 ID - Cheang2009 ER - TY - JOUR AU - Hammond, M. E. H. AU - Hayes, D. F. AU - Dowsett, M. AU - Allred, D. C. AU - Hagerty, K. L. AU - Badve, S. PY - 2010 DA - 2010// TI - American Society of Clinical Oncology, College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version) JO - Arch Pathol Lab Med VL - 134 ID - Hammond2010 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. H. AU - Schwartz, J. N. AU - Hagerty, K. L. AU - Allred, D. C. AU - Cote, R. J. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology, College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2775 DO - 10.1200/JCO.2006.09.2775 ID - Wolff2007 ER - TY - JOUR AU - Dueñas, E. M. AU - Hernández, A. L. AU - Zotano, A. G. AU - Carrión, R. M. P. AU - López-Muñiz, J. I. C. AU - Novoa, S. A. PY - 2014 DA - 2014// TI - Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009–03 ConvertHER study JO - Breast Cancer Res Treat VL - 143 UR - https://doi.org/10.1007/s10549-013-2825-2 DO - 10.1007/s10549-013-2825-2 ID - Dueñas2014 ER - TY - JOUR AU - Orlando, L. AU - Viale, G. AU - Schiavone, P. AU - Fedele, P. AU - Nacci, A. AU - Rizzo, P. PY - 2011 DA - 2011// TI - Discordance in pathology report after central pathology review in early breast cancer and its impact on treatment choice JO - ASCO Meeting Abstracts VL - 29 ID - Orlando2011 ER - TY - JOUR AU - Polley, M. -. Y. C. AU - Leung, S. C. Y. AU - McShane, L. M. AU - Gao, D. AU - Hugh, J. C. AU - Mastropasqua, M. G. PY - 2013 DA - 2013// TI - International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. An international Ki67 reproducibility study JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djt306 DO - 10.1093/jnci/djt306 ID - Polley2013 ER - TY - JOUR AU - Varga, Z. AU - Diebold, J. AU - Dommann-Scherrer, C. AU - Frick, H. AU - Kaup, D. AU - Noske, A. PY - 2012 DA - 2012// TI - How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0037379 DO - 10.1371/journal.pone.0037379 ID - Varga2012 ER - TY - JOUR AU - Varga, Z. AU - Cassoly, E. AU - Li, Q. AU - Oehlschlegel, C. AU - Tapia, C. AU - Lehr, H. A. PY - 2015 DA - 2015// TI - Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0123435 DO - 10.1371/journal.pone.0123435 ID - Varga2015 ER - TY - JOUR AU - Polley, M. -. Y. C. AU - Leung, S. C. Y. AU - Gao, D. AU - Mastropasqua, M. G. AU - Zabaglo, L. A. AU - Bartlett, J. M. S. PY - 2015 DA - 2015// TI - An international study to increase concordance in Ki67 scoring JO - Mod Pathol VL - 28 UR - https://doi.org/10.1038/modpathol.2015.38 DO - 10.1038/modpathol.2015.38 ID - Polley2015 ER - TY - JOUR AU - Lehmann-Che, J. AU - Amira-Bouhidel, F. AU - Turpin, E. AU - Antoine, M. AU - Soliman, H. AU - Legres, L. PY - 2011 DA - 2011// TI - Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches JO - Br J Cancer VL - 104 UR - https://doi.org/10.1038/bjc.2011.135 DO - 10.1038/bjc.2011.135 ID - Lehmann-Che2011 ER - TY - JOUR AU - Susini, T. AU - Bussani, C. AU - Marini, G. AU - Nori, J. AU - Olivieri, S. AU - Molino, C. PY - 2010 DA - 2010// TI - Preoperative assessment of HER-2/neu status in breast carcinoma: The role of quantitative real-time PCR on core-biopsy specimens JO - Gynecol Oncol VL - 116 UR - https://doi.org/10.1016/j.ygyno.2009.10.067 DO - 10.1016/j.ygyno.2009.10.067 ID - Susini2010 ER - TY - JOUR AU - Wilson, T. R. AU - Xiao, Y. AU - Spoerke, J. M. AU - Fridlyand, J. AU - Koeppen, H. AU - Fuentes, E. PY - 2014 DA - 2014// TI - Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples JO - Breast Cancer Res Treat VL - 148 UR - https://doi.org/10.1007/s10549-014-3163-8 DO - 10.1007/s10549-014-3163-8 ID - Wilson2014 ER - TY - JOUR AU - Noske, A. AU - Loibl, S. AU - Darb-Esfahani, S. AU - Roller, M. AU - Kronenwett, R. AU - Müller, B. M. PY - 2011 DA - 2011// TI - Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765) JO - Breast Cancer Res Treat VL - 126 UR - https://doi.org/10.1007/s10549-010-1316-y DO - 10.1007/s10549-010-1316-y ID - Noske2011 ER - TY - JOUR AU - Kim, C. AU - Tang, G. AU - Pogue-Geile, K. L. AU - Costantino, J. P. AU - Baehner, F. L. AU - Baker, J. PY - 2011 DA - 2011// TI - Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.32.9615 DO - 10.1200/JCO.2010.32.9615 ID - Kim2011 ER - TY - JOUR AU - Simon, R. M. AU - Paik, S. AU - Hayes, D. F. PY - 2009 DA - 2009// TI - Use of archived specimens in evaluation of prognostic and predictive biomarkers JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp335 DO - 10.1093/jnci/djp335 ID - Simon2009 ER - TY - JOUR AU - Teutsch, S. M. AU - Bradley, L. A. AU - Palomaki, G. E. AU - Haddow, J. E. AU - Piper, M. AU - Calonge, N. PY - 2009 DA - 2009// TI - EGAPP Working Group. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group JO - Genet Med VL - 11 UR - https://doi.org/10.1097/GIM.0b013e318184137c DO - 10.1097/GIM.0b013e318184137c ID - Teutsch2009 ER - TY - BOOK PY - 2014 DA - 2014// TI - Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline – Third Edition. CLSI document EP05-A3 PB - Clinical and Laboratory Standards Institute CY - Wayne ID - ref25 ER - TY - JOUR AU - Bustin, S. A. AU - Benes, V. AU - Garson, J. A. AU - Hellemans, J. AU - Huggett, J. AU - Kubista, M. PY - 2009 DA - 2009// TI - The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments JO - Clin Chem VL - 55 UR - https://doi.org/10.1373/clinchem.2008.112797 DO - 10.1373/clinchem.2008.112797 ID - Bustin2009 ER - TY - JOUR AU - Livak, K. J. AU - Schmittgen, T. D. PY - 2001 DA - 2001// TI - Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method JO - Methods VL - 25 UR - https://doi.org/10.1006/meth.2001.1262 DO - 10.1006/meth.2001.1262 ID - Livak2001 ER - TY - JOUR AU - Milde-Langosch, K. AU - Karn, T. AU - Müller, V. AU - Witzel, I. AU - Rody, A. AU - Schmidt, M. PY - 2013 DA - 2013// TI - Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer JO - Breast Cancer Res Treat VL - 137 UR - https://doi.org/10.1007/s10549-012-2296-x DO - 10.1007/s10549-012-2296-x ID - Milde-Langosch2013 ER - TY - STD TI - Wayne DW. CLSI Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline - Second Edition. CLSI document EP17-A2. Clinical and Laboratory Standards Institute; 2012. ID - ref29 ER - TY - JOUR AU - Vermeulen, J. AU - Pattyn, F. AU - Preter, K. D. AU - Vercruysse, L. AU - Derveaux, S. AU - Mestdagh, P. PY - 2009 DA - 2009// TI - External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data JO - Nucl Acids Res. VL - 37 UR - https://doi.org/10.1093/nar/gkp721 DO - 10.1093/nar/gkp721 ID - Vermeulen2009 ER - TY - JOUR AU - Norum, J. H. AU - Andersen, K. AU - Sørlie, T. PY - 2014 DA - 2014// TI - Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy JO - Br J Surg VL - 101 UR - https://doi.org/10.1002/bjs.9562 DO - 10.1002/bjs.9562 ID - Norum2014 ER - TY - JOUR AU - Kronenwett, R. AU - Bohmann, K. AU - Prinzler, J. AU - Sinn, B. V. AU - Haufe, F. AU - Roth, C. PY - 2012 DA - 2012// TI - Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-456 DO - 10.1186/1471-2407-12-456 ID - Kronenwett2012 ER - TY - JOUR AU - Goldhirsch, A. AU - Winer, E. P. AU - Coates, A. S. AU - Gelber, R. D. AU - Piccart-Gebhart, M. AU - Thürlimann, B. PY - 2013 DA - 2013// TI - Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt303 DO - 10.1093/annonc/mdt303 ID - Goldhirsch2013 ER - TY - JOUR AU - McCullough, A. E. AU - Dell’orto, P. AU - Reinholz, M. M. AU - Gelber, R. D. AU - Dueck, A. C. AU - Russo, L. PY - 2014 DA - 2014// TI - Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study JO - Breast Cancer Res Treat VL - 143 UR - https://doi.org/10.1007/s10549-013-2827-0 DO - 10.1007/s10549-013-2827-0 ID - McCullough2014 ER - TY - JOUR AU - Wasielewski, R. AU - Hasselmann, S. AU - Rüschoff, J. AU - Fisseler-Eckhoff, A. AU - Kreipe, H. PY - 2008 DA - 2008// TI - Proficiency testing of immunohistochemical biomarker assays in breast cancer JO - Virchows Arch VL - 453 UR - https://doi.org/10.1007/s00428-008-0688-4 DO - 10.1007/s00428-008-0688-4 ID - Wasielewski2008 ER - TY - JOUR AU - Perez, E. A. AU - Press, M. F. AU - Dueck, A. C. AU - Jenkins, R. B. AU - Kim, C. AU - Chen, B. PY - 2013 DA - 2013// TI - Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005) JO - Breast Cancer Res Treat VL - 138 UR - https://doi.org/10.1007/s10549-013-2444-y DO - 10.1007/s10549-013-2444-y ID - Perez2013 ER - TY - JOUR AU - Hardy, L. B. AU - Fitzgibbons, P. L. AU - Goldsmith, J. D. AU - Eisen, R. N. AU - Beasley, M. B. AU - Souers, R. J. PY - 2013 DA - 2013// TI - Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratories JO - Arch Pathol Lab Med VL - 137 UR - https://doi.org/10.5858/arpa.2011-0676-CP DO - 10.5858/arpa.2011-0676-CP ID - Hardy2013 ER - TY - JOUR AU - Nakhleh, R. E. AU - Grimm, E. E. AU - Idowu, M. O. AU - Souers, R. J. AU - Fitzgibbons, P. L. PY - 2010 DA - 2010// TI - Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories JO - Arch Pathol Lab Med VL - 134 ID - Nakhleh2010 ER - TY - JOUR AU - Dyhdalo, K. S. AU - Fitzgibbons, P. L. AU - Goldsmith, J. D. AU - Souers, R. J. AU - Nakhleh, R. E. PY - 2014 DA - 2014// TI - Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures JO - Arch Pathol Lab Med VL - 138 UR - https://doi.org/10.5858/arpa.2013-0731-CP DO - 10.5858/arpa.2013-0731-CP ID - Dyhdalo2014 ER - TY - JOUR AU - Reisenbichler, E. S. AU - Lester, S. C. AU - Richardson, A. L. AU - Dillon, D. A. AU - Ly, A. AU - Brock, J. E. PY - 2013 DA - 2013// TI - Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: a demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification JO - Am J Clin Pathol VL - 140 UR - https://doi.org/10.1309/AJCP1RF9FUIZRDPI DO - 10.1309/AJCP1RF9FUIZRDPI ID - Reisenbichler2013 ER - TY - JOUR AU - Kotoula, V. AU - Kalogeras, K. T. AU - Kouvatseas, G. AU - Televantou, D. AU - Kronenwett, R. AU - Wirtz, R. M. PY - 2013 DA - 2013// TI - Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research JO - Virchows Arch VL - 462 UR - https://doi.org/10.1007/s00428-012-1357-1 DO - 10.1007/s00428-012-1357-1 ID - Kotoula2013 ER - TY - JOUR AU - Park, K. AU - Han, S. AU - Kim, H. J. AU - Kim, J. AU - Shin, E. PY - 2006 DA - 2006// TI - HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry JO - Histopathology VL - 48 UR - https://doi.org/10.1111/j.1365-2559.2006.02403.x DO - 10.1111/j.1365-2559.2006.02403.x ID - Park2006 ER -